A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial

Lancet

Volumn 370, Issue 9583, 2007, Pages 240-250

  Pieters, Rob ^a   Schrappe, Martin ^b   De Lorenzo, Paola ^c   Hann, Ian ^e   De Rossi, Giulio ^f   Felice, Maria ^g   Hovi, Liisa ^h   LeBlanc, Thierry ⁱ   Szczepanski, Tomasz ^j   Ferster, Alice ^k   Janka, Gritta ^l   Rubnitz, Jeffrey ^m   Silverman, Lewis ⁿ   Stary, Jan ^o   Campbell, Myriam ^p   Li, Chi Kong ^q   Mann, Georg ^r   Suppiah, Ram ^s   Biondi, Andrea ^f   Vora, Ajay ^c   Valsecchi, Maria Grazia ^d   more..

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

^d GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^e SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

^f BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^g HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

^h UNIVERSITY OF HELSINKI   (Finland)

ⁱ SAINT LOUIS HOSPITAL   (France)

^j MEDICAL UNIVERSITY OF SILESIA   (Poland)

^k HOP UNIV DES ENFANTS REINE FABIOLA   (Belgium)

^l UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^m ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

ⁿ DANA FARBER CANCER INSTITUTE   (United States)

^o UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^p HOSPITAL ROBERTO DEL RÍO   (Chile)

^q CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^r ST ANNA CHILDREN S HOSPITAL   (Austria)

^s WOMEN S AND CHILDREN S HOSPITAL   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; ETOPOSIDE; FOLINIC ACID; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; TIOGUANINE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER RISK; CLINICAL OBSERVATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE INTERVAL; DRUG MEGADOSE; FEMALE; FOLLOW UP; GENE REARRANGEMENT; HUMAN; INFANT; INFECTION; LIVER TOXICITY; LOADING DRUG DOSE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MLL GENE; MUCOSA INFLAMMATION; MULTICENTER STUDY; NEPHROTOXICITY; NEUROTOXICITY; ONCOGENE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RARE DISEASE; STEROID THERAPY; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 34447519040     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(07)61126-X     Document Type: Article

References (31)

1. Pieters R. Biology and treatment of infant leukemias. In: Pui C. (Ed). Treatment of acute leukemias: new directions for clinical research (2003), Humana Press, Totowa, NJ, USA 61-73
2. Biondi A., Cimino G., Pieters R., and Pui C. Biological and therapeutic insights of infant leukemia. Blood 96 (2000) 24-33
3. Silverman L., McLean T., Gelber R., et al. Intensified therapy for infants with acute lymphoblastic leukemia: results from the Dana Farber Cancer Institute Consortium. Cancer 80 (1997) 2285-2295
4. Biondi A., Rizzari C., Valsecchi M., et al. Role of treatment intensification in infants with acute lymphoblastic leukemia: results of two consecutive AIEOP studies. Haematologica 91 (2006) 534-537
5. Dordelmann M., Reiter A., Borkhardt A., et al. Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia. Blood 94 (1999) 1209-1217
6. Ferster A., Bertrand Y., Benoit Y., et al. Improved survival for acute lymphoblastic leukaemia in infancy: the experience of EORTC-Childhood Leukaemia Cooperative Group. Br J Haematol 86 (1994) 284-290
7. Hilden J., Dinndorf P., Meerbaum S., et al. Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group. Blood 108 (2006) 441-451
8. Reaman G., Sposto R., Sensel M., et al. Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group. J Clin Oncol 17 (1999) 445-455
9. Chessells J., Harrison C., Watson S., et al. Treatment of infants with lymphoblastic leukemia: results of the UK Infant Protocols 1987-1999. Br J Haematol 117 (2002) 306-314
10. Frankel L., Ochs J., Shuster J., et al. Therapeutic trial for infant acute lymphoblastic leukemia: the Pediatric Oncology Group experience (POG 8493). J Ped Hematol Oncol 19 (1997) 35-42
11. Lauer S., Camitta B., Leventhal B., et al. Intensive alternating drug pairs after remission induction for treatment of infants with acute lymphoblastic leukemia: a Pediatric Oncology Group pilot study. J Ped Hematol Oncol 20 (1998) 229-233
12. Reiter A., Schrappe M., Ludwig W.-D., et al. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood 84 (1994) 3122-3133
13. Pieters R., den Boer M., Durian M., et al. Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia-implications for treatment of infants. Leukemia 12 (1998) 1344-1348
14. Stam R., den Boer M., Meijerink J., et al. Differential mRNA expression of Ara-C metabolizing enzymes explains Ara-C sensitivity in MLL gene-rearranged infant acute lymphoblastic leukemia. Blood 101 (2003) 1270-1276
15. Ludwig W., Rieder H., Bartram C., et al. Immunophenotypic and genotypic features, clinical characteristics, and treatment outcome of adult pro-B acute lymphoblastic leukemia: results of the German multicenter trials GMALL 03/87 and 04/89. Blood 92 (1998) 1898-1909
16. Heerema N., Sather H., Ge J., et al. Cytogenetic studies of infant acute lymphoblastic leukemia: poor prognosis of infants with t (4; 11)-a report of the Children's Cancer Group. Leukemia 13 (1999) 679-686
17. Pui C., and Evans W. Treatment of acute lymphoblastic leukemia. N Engl J Med 354 (2006) 166-178
18. Creutzig U., Zimmermann M., Ritter J., et al. Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials. Leukemia 19 (2005) 2030-2042
19. O'Brian P., and Fleming T. A multiple testing procedure for clinical trials. Biometrics 35 (1979) 549-556
20. Fayers P., Ashby D., and Parmar M. Bayesian data monitoring in clinical trials. Stat Med 16 (1997) 1413-1430
21. Marubini E., and Valsecchi M. The Cox regression model. In: Marubini E., and Valsecchi M. (Eds). Analysing survival data from clinical trials and observational studies (1995), John Wiley, Chichester, UK 171-222
22. Nagayama J., Tomizawa D., Koh K., et al. Infants with acute lymphoblastic leukemia and a germline MLL gene are highly curable with use of chemotherapy alone: results from the Japan Infant Leukemia Study group. Blood 107 (2006) 4663-4665
23. Leung W., Hudson M., Zhu Y., et al. Late effects in survivors of infant leukemia. Leukemia 14 (2000) 1185-1190
24. White J., Rathmell J., and Capizzi R. Membrane transport influences the rate of accumulation of cytosine arabinoside in human leukemia cells. J Clin Invest 79 (1987) 380-387
25. Wiley J., Jones S., Sawyer W., et al. Cytosine arabinoside influx and nucleoside transport sites in acute leukemia. J Clin Invest 69 (1982) 479-489
26. Kosaka Y., Koh K., Kinukawa N., et al. Infant acute lymphoblastic leukemia with MLL gene rearrangements: outcome following intensive chemotherapy and hematopoietic stem cell transplantation. Blood 104 (2004) 3527-3534
27. Marco F., Bureo E., Ortega J., et al. High survival rate in infant acute leukemia treated with early high-dose chemotherapy and stem-cell support. J Clin Oncol 18 (2000) 3256-3261
28. Sanders J., Joon I.H., Hoffmeister P., et al. Allogeneic hematopoietic transplantation for infants with acute lymphoblastic leukemia. Blood 105 (2005) 3749-3756
29. Pui C., Gaynon P., Boyett J., et al. Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region. Lancet 359 (2002) 1909-1915
30. Jansen M., Corral L., van der Velden V., et al. Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangement. Leukemia 21 (2007) 633-641
31. Stam R., den Boer M., and Pieters R. Toward targeted therapy for infant acute lymphoblastic leukaemia. Br J Haematol 132 (2006) 539-551